Previously, Montclare had developed a protein-lipid system capable of carrying not only small-molecule therapeutic drugs but nucleic acids for gene therapy at the same time, as a dual payload, in order to treat cancer, diabetes, and other conditions requiring a variety of therapeutic approaches.

"The strides Jin Montclare has made in protein engineering exemplify Tandon and NYU's commitment to collaborative, translational research with the potential to positively impact healthcare for countless patients," said NYU Tandon Dean Jelena Kovačevi?. "We are proud that she is effectively addressing problems of such great medical and societal importance."


The work on F-TRAP was supported by the National Science Foundation and the National Institutes of Health National Center for Advancing Translational Sciences. The paper is available at https://pubs.acs.org/doi/10.1021/acsnano.8b07481.


About the New York University Tandon School of Engineering
The NYU Tandon School of Engineering dates to 1854, the founding date for both the New York University School of Civil Engineering and Architecture and the Brooklyn Collegiate and Polytechnic Institute (widely known as Brooklyn Poly). A January 2014 merger created a comprehensive school of education and research in engineering and applied sciences, rooted in a tradition of invention and entrepreneurship and dedicated to furthering technology in service to society. In addition to its main location in Brooklyn, NYU Tandon collaborates with other schools within NYU, one of the country's foremost private research universities, and is closely connected to engineering programs at NYU Abu Dhabi and NYU Shanghai. It operates Future Labs focused on start-up businesses in downtown Manhattan and Brooklyn and an award-winning online graduate program.

Back to HCB News

MRI Homepage